The inverted CD4: CD8 ratio is associated with gender-related changes in oxidative stress during aging

Cellular Immunology

Volumn 296, Issue 2, 2015, Pages 149-154

  Muller, Guilherme Cerutti ^a,b   Gottlieb, Maria Gabriela Valle ^a   Luz Correa, Bruna ^a   Filho, Irênio Gomes ^a   Moresco, Rafael Noal ^c   Bauer, Moisés Evandro ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE DO VALE DO RIO DOS SINOS   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antioxidant power; Cytomegalovirus; Immune risk profile; Immunosenescence; Inflammation; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; IMMUNOGLOBULIN G; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; VIRUS ANTIBODY;

ADULT; AGED; AGING; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CD4 CD8 RATIO; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; FERRIC REDUCING ABILITY OF PLASMA; GENDER; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOSENESCENCE; INFLAMMATION; LIPID OXIDATION; MALE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE SUBPOPULATION; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PATHOLOGY; SEX DIFFERENCE; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; AGING; ANTIBODIES, VIRAL; C-REACTIVE PROTEIN; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-6; MALE; MIDDLE AGED; OXIDATIVE STRESS; SEX FACTORS; T-LYMPHOCYTE SUBSETS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84942596742     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.05.006     Document Type: Article

References (70)

1. Strindhall J., et al. No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. 2007, 42(8):753-761.
2. Strindhall J., et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) 2013, 35(3):985-991.
3. Luz Correa B., et al. The inverted CD4:CD8 ratio is associated with cytomegalovirus, poor cognitive and functional states in older adults. Neuroimmunomodulation 2014, 21(4):206-212.
4. Olsson J., et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121(1-3):187-201.
5. Nilsson B.O., et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA immune study using sample selection protocols. Mech. Ageing Dev. 2003, 124(4):469-476.
6. Syrjala H., Surcel H.M., Ilonen J. Low CD4/CD8 T lymphocyte ratio in acute myocardial infarction. Clin. Exp. Immunol. 1991, 93:326-328.
7. Sainz T., et al. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. AIDS 2013, 27(9):1513-1516.
8. Lee Y.W., et al. Immunological impact of Taekwondo competitions. Int. J. Sports Med. 2012, 33:58-66.
9. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 2004, 130:601-630.
10. Derhovanessian E., Larbi A., Pawelec G. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Curr. Opin. Immunol. 2009, 21(4):440-445.
11. Aw D., Silva A.B., Palmer D.B. Immunosenescence: emerging challenges for an ageing population. Immunology 2007, 120:435-446.
12. Khan N., et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 2002, 169(4):1984-1992.
13. Mehrotra S., et al. Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet. Med. 2001, 18(2):109-115.
14. Witko-Sarsat V., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49(5):1304-1313.
15. Kasapoglu M., Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp. Gerontol. 2001, 36(2):209-220.
16. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 1996, 239(1):70-76.
17. Tse H.M., et al. Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J. Immunol. 2007, 178(2):908-917.
18. Drew B., Leeuwenburgh C. Aging and the role of reactive nitrogen species. Ann. N.Y. Acad. Sci. 2002, 959:66-81.
19. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11(3):298-300.
20. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diab. Care 1996, 19(3):257-267.
21. Rodrigues R., Petersen R.B., Perry G. Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability. Cell Mol. Neurobiol. 2014, 34(7):925-949.
22. Prats M., et al. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients. Clin. Nephrol. 2014, 81(6):419-426.
23. Chang Y.T., et al. The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review. Biomed. Res. Int. 2014, 2014:182303.
24. Gutowski M., Kowalczyk S. A study of free radical chemistry: their role and pathophysiological significance. Acta Biochim. Pol. 2013, 60(1):1-16.
25. Trujillo J.A., et al. The cellular redox environment alters antigen presentation. J. Biol. Chem. 2014, 289(40):27979-27991.
26. Chakrabarti S., Jahandideh F., Wu J. Food-derived bioactive peptides on inflammation and oxidative stress. Biomed. Res. Int. 2014, 2014:608979.
27. Cesari M., et al. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67(6):671-676.
28. Jaganjac M., et al. Induction of CMV-1 promoter by 4-hydroxy-2-nonenal in human embryonic kidney cells. Acta Biochim. Pol. 2010, 57(2):179-183.
29. Lee Y.L., et al. Presence of cytomegalovirus DNA in leucocytes is associated with increased oxidative stress and subclinical atherosclerosis in healthy adults. Biomarkers 2014, 19(2):109-113.
30. Scholz M., et al. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Transplantation 1996, 61(12):1763-1770.
31. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18(6):499-502.
32. Hanasand M., et al. Improved detection of advanced oxidation protein products in plasma. Clin. Chim. Acta 2012, 413(9-10):901-906.
33. Vargas H.O., et al. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci. Lett. 2013, 544:136-140.
34. Skvarilova M., et al. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 2005, 149(1):83-87.
35. Hadzovic-Dzuvo A., et al. Oxidative stress status in elite athletes engaged in different sport disciplines. Bosn. J. Basic Med. Sci. 2014, 14(2):56-62.
36. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 1990, 9(6):515-540.
37. Andriollo-Sanchez M., et al. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur. J. Clin. Nutr. 2005, 59(Suppl. 2):S58-S62.
38. Goraca A., Skibska B. Plasma antioxidant status in healthy smoking and non-smoking men. Bratisl. Lek. Listy 2005, 106(10):301-306.
39. Nemes E., et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A 2015, 87(2):157-165.
40. Pawelec G., Derhovanessian E. Role of CMV in immune senescence. Virus Res. 2011, 157(2):175-179.
41. Alonso Arias R. Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J. Virol. 2013, 87(8):4486-4495.
42. Wikby A., et al. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 2002, 37(2-3):445-453.
43. Fulop T., et al. Aging, frailty and age-related diseases. Biogerontology 2010, 11(5):547-563.
44. Wikby A., et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech. Ageing Dev. 2006, 127(8):695-704.
45. Moylan J.S., Reid M.B. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 2007, 35(4):411-429.
46. Chung H.Y., et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8(1):18-30.
47. Brinkley T.E., et al. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64(4):455-461.
48. DelaRosa O., et al. Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology 2006, 7(5-6):471-481.
49. Pawelec G., Goldeck D., Derhovanessian E. Inflammation, ageing and chronic disease. Curr. Opin. Immunol. 2014, 29C:23-28.
50. Guo C.H., et al. Role of certain trace minerals in oxidative stress, inflammation, CD4/CD8 lymphocyte ratios and lung function in asthmatic patients. Ann. Clin. Biochem. 2011, 48(Pt 4):344-351.
51. Vasson M.P., et al. Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and Spain. Immun. Ageing 2013, 10(1):38.
52. Collerton J., et al. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech. Ageing Dev. 2012, 133(6):456-466.
53. Derhovanessian E., et al. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 2010, 185(8):4618-4624.
54. Hyland P., et al. Nonagenarians from the Swedish NONA Immune Study have increased plasma antioxidant capacity and similar levels of DNA damage in peripheral blood mononuclear cells compared to younger control subjects. Exp. Gerontol. 2002, 37(2-3):465-473.
55. Koch S.D., Kempf J., Pawelec G. T cell immunity and aging. Sci. Aging Knowledge Environ. 2005, 2005(48):pe37.
56. Wikby A., et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech. Ageing Dev. 1998, 102(2-3):187-198.
57. Saurwein-Teissl M., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 2002, 168(11):5893-5899.
58. Crough T., Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 2009, 22(1):76-98.
59. Chidrawar S., et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 2009, 155(3):423-432.
60. Ouyang Q., et al. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp. Gerontol. 2004, 39(4):607-613.
61. Hadrup S.R., et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 2006, 176(4):2645-2653.
62. Lee J., et al. Upregulation of Nrf2 expression by human cytomegalovirus infection protects host cells from oxidative stress. J. Gen. Virol. 2013, 94(Pt 7):1658-1668.
63. Wertheimer A.M., et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J. Immunol. 2014, 192(5):2143-2155.
64. Brunelli E., et al. Sex differences in oxidative stress biomarkers. Curr. Drug Targets 2014, 15(8):811-815.
65. Goldfarb A.H., McKenzie M.J., Bloomer R.J. Gender comparisons of exercise-induced oxidative stress: influence of antioxidant supplementation. Appl. Physiol. Nutr. Metab. 2007, 32(6):1124-1131.
66. Ji L.L. Exercise at old age: does it increase or alleviate oxidative stress?. Ann. N.Y. Acad. Sci. 2001, 928:236-247.
67. Bonetto A., et al. Are antioxidants useful for treating skeletal muscle atrophy?. Free Radic. Biol. Med. 2009, 47(7):906-916.
68. Bautmans I., et al. Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60(3):361-367.
69. Derbre F., et al. Inactivity-induced oxidative stress: a central role in age-related sarcopenia?. Eur. J. Sport Sci. 2014, 14(Suppl. 1):S98-S108.
70. Doria E., et al. Relationship between human aging muscle and oxidative system pathway. Oxid. Med. Cell Longev. 2012, 2012:830257.